Structure of the Murine Unglycosylated IgG1 Fc Fragment

Journal of Molecular Biology

Volumn 391, Issue 3, 2009, Pages 599-608

  Feige, Matthias J ^a   Nath, Susanne ^b   Catharino, Silvia R ^a   Weinfurtner, Daniel ^a   Steinbacher, Stefan ^a   Buchner, Johannes ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

antibody effector functions; antibody stability; antibody structure; glycosylation; IgG1

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G1;

ANTIBODY STRUCTURE; ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DEGLYCOSYLATION; GLYCOSYLATION; IMMUNOGLOBULIN STRUCTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN ISOLATION; PROTEIN STABILITY; PROTEIN STRUCTURE; RECEPTOR BINDING; STRUCTURE ANALYSIS;

MURINAE;

EID: 67651149465     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2009.06.048     Document Type: Article

References (38)

1. Huber R., Deisenhofer J., Colman P.M., Matsushima M., and Palm W. Crystallographic structure studies of an IgG molecule and an Fc fragment. Nature 5585 (1976) 415-420
2. Ravetch J.V., and Clynes R.A. Divergent roles for Fc receptors and complement in vivo. Annu. Rev. Immunol. 16 (1998) 421-432
3. Gergely J., Sarmay G., and Rajnavolgyi E. Regulation of antibody-production mediated by Fc-gamma receptors, IgG binding-factors, and IgG Fc-binding autoantibodies. Crit. Rev. Biochem. Mol. Biol. 3 (1992) 191-225
4. Morgan E.L., Hobbs M.V., Thoman M.T., and Weigle W.O. Lymphocyte-activation by the Fc region of immunoglobulins. Immunol. Invest. 7 (1986) 625-687
5. Mimura Y., Sondermann P., Ghirlando R., Lund J., Young S.P., Goodall M., and Jefferis R. Role of oligosaccharide residues of IgG1-Fc in Fc gamma RIIb binding. J. Biol. Chem. 276 (2001) 45539-45547
6. Mimura Y., Church S., Ghirlando R., Ashton P.R., Dong S., Goodall M., and Jefferis R. The influence of glycosylation on the thermal stability and effector function expression of human IgG1-Fc: properties of a series of truncated glycoforms. Mol. Immunol. 37 (2000) 697-706
7. Lund J., Tanaka T., Takahashi N., Sarmay G., Arata Y., and Jefferis R. A protein structural change in aglycosylated IgG3 correlates with loss of huFc gamma R1 and huFc gamma R111 binding and/or activation. Mol. Immunol. 27 (1990) 1145-1153
8. Leatherbarrow R.J., Rademacher T.W., Dwek R.A., Woof J.M., Clark A., Burton D.R., et al. Effector functions of a monoclonal aglycosylated mouse Igg2A-binding and activation of complement component C1 and interaction with human monocyte Fc-receptor. Mol. Immunol. 4 (1985) 407-415
9. Dwek R.A., Lellouch A.C., and Wormald M.R. Glycobiology-the function of sugar in the IgG molecule. J. Anat. 187 (1995) 279-292
10. Galon J., Robertson M.W., Galinha A., Mazieres N., Spagnoli R., Fridman W.H., and Sautes C. Affinity of the interaction between Fc gamma receptor type III (Fc gamma RIII) and monomeric human IgG subclasses. Role of Fc gamma RIII glycosylation. Eur. J. Immunol. 8 (1997) 1928-1932
11. Tao M.H., and Morrison S.L. Studies of aglycosylated chimeric mouse-human IgG-role of carbohydrate in the structure and effector functions mediated by the human IgG constant region. J. Immunol. 8 (1989) 2595-2601
12. Arnold J.N., Wormald M.R., Sim R.B., Rudd P.M., and Dwek R.A. The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu. Rev. Immunol. 25 (2007) 21-50
13. Nimmerjahn F., and Ravetch J.V. Fc[gamma] receptors as regulators of immune responses. Nat. Rev. Immunol. 1 (2008) 34-47
14. Ghirlando R., Lund J., Goodall M., and Jefferis R. Glycosylation of human IgG-Fc: influences on structure revealed by differential scanning micro-calorimetry. Immunol. Lett. 1 (1999) 47-52
15. Sondermann P., Huber R., Oosthuizen V., and Jacob U. The 3.2-Å crystal structure of the human IgG1 Fc fragment-FcRIII complex. Nature 406 (2000) 267-273
16. Lilie H., Rudolph R., and Buchner J. Association of antibody chains at different stages of folding: prolyl isomerization occurs after formation of quaternary structure. J. Mol. Biol. 1 (1995) 190-201
17. Lilie H., McLaughlin S., Freedman R., and Buchner J. Influence of protein disulfide isomerase (PDI) on antibody folding in vitro. J. Biol. Chem. 19 (1994) 14290-14296
18. Thies M., Mayer J., Augustine J., Frederick C., Lilie H., and Buchner J. Folding and association of the antibody domain CH3: prolyl isomerization preceeds dimerization. J. Mol. Biol. 293 (1999) 67-79
19. Feige M.J., Walter S., and Buchner J. Folding mechanism of the CH2 antibody domain. J. Mol. Biol. 1 (2004) 107-118
20. Feige M.J., Groscurth S., Marcinowski M., Yew Z.T., Truffault V., Paci E., et al. The structure of a folding intermediate provides insight into differences in immunoglobulin amyloidogenicity. Proc. Natl Acad. Sci. USA 36 (2008) 13373-13378
21. Krapp S., Mimura Y., Jefferis R., Huber R., and Sondermann P. Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity. J. Mol. Biol. 5 (2003) 979-989
22. Vinci F., Catharino S., Frey S., Buchner J., Gennaro M., Pucci P., and Ruoppolo M. Hierarchical formation of disulfide bonds in the immunoglobulin Fc fragment is assisted by protein-disulfide isomerase. Biol. Chem. 279 (2004) 15059-15066
23. Laskowski R.A., McArthur M.W., Moss D.S., and Thronton J.M. PROCHECK-a programm to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26 (1993) 283-291
24. Deisenhofer J. Crystallographic refinement and atomic models of a human fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9 and 2.8 Å resolution. Biochemistry 20 (1981) 2361-2370
25. Schmid F.X. Prolyl isomerase: enzymatic catalysis of slow protein-folding reactions. Annu. Rev. Biophys. Biomol. Struct. 22 (1993) 123-142
26. Kornfeld R., and Kornfeld S. Assembly of asparagine-linked oligosaccharides. Annu. Rev. Biochem. 54 (1985) 631-664
27. Matsumiya S., Yamaguchi Y., Saito J., Nagano M., Sasakawa H., Otaki S., et al. Structural comparison of fucosylated and nonfucosylated Fc fragments of human immunoglobulin G1. J. Mol. Biol. 3 (2007) 767-779
28. Yamaguchi Y., Nishimura M., Nagano M., Yagi H., Sasakawa H., Uchida K., et al. Glycoform-dependent conformational alteration of the Fc region of human immunoglobulin G1 as revealed by NMR spectroscopy. Biochim. Biophys. Acta 4 (2006) 693-700
29. Prabakaran P., Vu B.K., Gan J., Feng Y., Dimitrov D.S., and Ji X. Structure of an isolated unglycosylated antibody CH3 domain. Acta Crystallogr. Sect. D 64 (2008) 1062-1067
30. Matsuda H., Nakamura S., Ichikawa Y., Kozai K., Takano R., Nose M., et al. Proton nuclear magnetic resonance studies of the structure of the Fc fragment of human immunoglobulin G1: comparisons of native and recombinant proteins. Mol. Immunol. 27 (1990) 571-579
31. Otwinowski Z., and Minor W. Proceedings of X-ray diffraction data collected in oscillations mode. Methods Enzymol. 276 (1997) 307-326
32. CCP4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. Sect. D 50 (1994) 760-763
33. Turk, D. (1992). Weiterentwicklung eines Programmes für Molekülgraphik und Elektronendichte-Manipulation und seine Anwendung auf verschiedene Protein-Strukturaufklärungen. PhD Thesis.
34. Brünger A. Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature 355 (1992) 472-475
35. Ramachandran G.N., and Sasisekharan V. Conformation of polypeptides and proteins. Adv. Protein Chem. 23 (1968) 283-437
36. Kraulis P.J.J. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. Appl. Crystallogr. 24 (1991) 946-950
37. Esnouf R.M. An extensively modified version of MolScript that includes greatly enhanced coloring capabilities. J. Mol. Graph. Model. 15 (1997) 132-134
38. Merritt E.A., and Bacon D.J. Raster3D: photorealistic molecular graphics. Methods Enzymol. 277 (1997) 505-524